Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does EMPAGLIFLOZIN Cause Atrial fibrillation? 219 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 219 reports of Atrial fibrillation have been filed in association with EMPAGLIFLOZIN (Jardiance). This represents 0.6% of all adverse event reports for EMPAGLIFLOZIN.

219
Reports of Atrial fibrillation with EMPAGLIFLOZIN
0.6%
of all EMPAGLIFLOZIN reports
12
Deaths
134
Hospitalizations

How Dangerous Is Atrial fibrillation From EMPAGLIFLOZIN?

Of the 219 reports, 12 (5.5%) resulted in death, 134 (61.2%) required hospitalization, and 26 (11.9%) were considered life-threatening.

Is Atrial fibrillation Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for EMPAGLIFLOZIN. However, 219 reports have been filed with the FAERS database.

What Other Side Effects Does EMPAGLIFLOZIN Cause?

Diabetic ketoacidosis (3,644) Fungal infection (1,941) Blood glucose increased (1,797) Euglycaemic diabetic ketoacidosis (1,769) Weight decreased (1,661) Urinary tract infection (1,439) Ketoacidosis (1,411) Dizziness (1,372) Nausea (1,333) Vomiting (1,201)

What Other Drugs Cause Atrial fibrillation?

APIXABAN (5,690) IBRUTINIB (3,671) LENALIDOMIDE (2,704) RITUXIMAB (2,100) SACUBITRIL\VALSARTAN (2,062) RIVAROXABAN (2,027) ADALIMUMAB (1,709) METOPROLOL (1,462) DEXAMETHASONE (1,461) METHOTREXATE (1,411)

Which EMPAGLIFLOZIN Alternatives Have Lower Atrial fibrillation Risk?

EMPAGLIFLOZIN vs EMPAGLIFLOZIN\LINAGLIPTIN EMPAGLIFLOZIN vs EMPAGLIFLOZIN\LINAGLIPTIN\METFORMIN EMPAGLIFLOZIN vs EMPAGLIFLOZIN\METFORMIN EMPAGLIFLOZIN vs EMSAM EMPAGLIFLOZIN vs EMTRICITABINE

Related Pages

EMPAGLIFLOZIN Full Profile All Atrial fibrillation Reports All Drugs Causing Atrial fibrillation EMPAGLIFLOZIN Demographics